STAT3 and Miyoshi myopathy: Combined treatment of MM cells with PIs and a MTH1 inhibitor induced synergistic effects, whereas co‐treatment of MM cells with PIs and STAT3, STAT6 or MAPK inhibitors only mildly increased cell death